137 related articles for article (PubMed ID: 6818900)
1. Synergism between N-formimidoyl thienamycin and gentamicin or tobramycin against enterococci.
Watanakunakorn C; Tisone JC
Antimicrob Agents Chemother; 1982 Dec; 22(6):1082-3. PubMed ID: 6818900
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis.
Gombert ME; Berkowitz LB; Cummings MC
Antimicrob Agents Chemother; 1983 Feb; 23(2):245-7. PubMed ID: 6404218
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.
Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1981 May; 19(5):789-93. PubMed ID: 6794445
[TBL] [Abstract][Full Text] [Related]
4. Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.
Indrelie JA; Wilson WR; Matsumoto JY; Geraci JE; Washington JA
Antimicrob Agents Chemother; 1984 Dec; 26(6):909-12. PubMed ID: 6596907
[TBL] [Abstract][Full Text] [Related]
5. Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin.
Moellering RC; Wennersten C; Weinstein AJ
Antimicrob Agents Chemother; 1973 Apr; 3(4):526-9. PubMed ID: 4208292
[TBL] [Abstract][Full Text] [Related]
6. Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.
Aznar J; García Iglesias MC; Perea EJ
J Antimicrob Chemother; 1984 Feb; 13(2):129-32. PubMed ID: 6423613
[TBL] [Abstract][Full Text] [Related]
7. N-formimidoyl thienamycin: in vitro comparison with cefoxitin and tobramycin against clinical, bacterial isolates.
Digranes A; Dibb WL; Benonisen E
Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):141-4. PubMed ID: 6603093
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.
Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A
Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899
[TBL] [Abstract][Full Text] [Related]
9. Interaction of cefotaxime and aminoglycosides against enterococci in vitro.
Elliott AM; Karam GH; Cobbs CG
Antimicrob Agents Chemother; 1983 Dec; 24(6):847-50. PubMed ID: 6318661
[TBL] [Abstract][Full Text] [Related]
10. Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.
Auckenthaler R; Wilson WR; Wright AJ; Washington JA; Durack DT; Geraci JE
Antimicrob Agents Chemother; 1982 Sep; 22(3):448-52. PubMed ID: 6958215
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
[TBL] [Abstract][Full Text] [Related]
12. In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
Matzkowitz AJ; Baltch AL; Smith RP; Sutphen NT; Hammer MC; Conroy JV
Antimicrob Agents Chemother; 1982 Apr; 21(4):685-7. PubMed ID: 6805426
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ceftazidime and N-formimidoyl thienamycin against gentamicin-susceptible and resistant Pseudomonas aeruginosa.
Alford RH
J Antimicrob Chemother; 1983 Jun; 11(6):599-601. PubMed ID: 6411675
[No Abstract] [Full Text] [Related]
14. Comparative in vitro activity of nafcillin, oxacillin, and methicillin in combination with gentamicin and tobramycin against enterococci.
Watanakunakorn C; Glotzbecker C
Antimicrob Agents Chemother; 1977 Jan; 11(1):88-91. PubMed ID: 836017
[TBL] [Abstract][Full Text] [Related]
15. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
Bartmann K; Tarbuc R
Infection; 1982; 10(6):361-70. PubMed ID: 6818153
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of LY 146032, a novel cyclic lipopeptide, alone and in combination with gentamicin or tobramycin against enterococci.
Watanakunakorn C
J Antimicrob Chemother; 1987 Apr; 19(4):445-8. PubMed ID: 3034849
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
Melby K; Midtvedt T; Dahl O
Chemotherapy; 1979; 25(5):286-95. PubMed ID: 113179
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Pusztai-Markos Z; Pranada F
Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
[TBL] [Abstract][Full Text] [Related]
19. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
Watanakunakorn C; Tisone JC
Antimicrob Agents Chemother; 1982 Nov; 22(5):903-5. PubMed ID: 6924825
[TBL] [Abstract][Full Text] [Related]
20. Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa.
Michael PR; Alford RH; McGee ZA
Antimicrob Agents Chemother; 1981 Nov; 20(5):702-4. PubMed ID: 6798926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
